Pascoe Richard W
- SEC CIK
- 0001343266
No open-market purchases or sales filed in the past year.
Current role at each company
- SEEL Seelos Therapeutics, Inc.Directoras of Jan 8, 2024
- ZVRA Zevra Therapeutics, Inc.Chief Executive Officeras of Mar 13, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Pascoe Richard W as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ZVRA Zevra Therapeutics, Inc.
Chief Executive Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2023 (view filing) | Mar 9 | 4 days | Pascoe Richard WChief Executive Officer | PPurchase | +10.0K | $4.20 | +$42.0K | +50.1%30.0K after | |
| Jan 13, 2023 (view filing) | Jan 13 | Same day | Pascoe Richard WChief Executive Officer | PPurchase | +9.50K | $5.44 | +$51.7K | +90.7%20.0K after | |
| May 18, 2022 (view filing) | May 18 | Same day | Pascoe Richard WExecutive Chairman | PPurchase | +5.00K | $4.92 | +$24.6K | +152.2%8.29K after | 7 lots |
| Nov 30, 2021 (view filing) | Nov 30 | Same day | Pascoe Richard WExecutive Chairman | PPurchase | +1.50K | $7.88 | +$11.8K | +84.0%3.29K after |